Savara Inc. (SVRA)
NASDAQ: SVRA · Real-Time Price · USD
2.390
+0.090 (3.91%)
At close: Jul 11, 2025, 4:00 PM
2.380
-0.010 (-0.42%)
After-hours: Jul 11, 2025, 7:33 PM EDT
Savara Market Cap
Savara has a market cap or net worth of $503.55 million as of July 11, 2025. Its market cap has decreased by -4.10% in one year.
Market Cap
503.55M
Enterprise Value
359.94M
1-Year Change
-4.10%
Ranking
Category
Stock Price
$2.39
Market Cap Chart
Since April 28, 2017, Savara's market cap has increased from $132.70M to $503.55M, an increase of 279.46%. That is a compound annual growth rate of 17.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 11, 2025 | 413.10M | -21.60% |
| Dec 31, 2024 | 526.90M | -17.17% |
| Dec 29, 2023 | 636.10M | 259.79% |
| Dec 30, 2022 | 176.80M | 25.21% |
| Dec 31, 2021 | 141.20M | 126.65% |
| Dec 31, 2020 | 62.30M | -66.25% |
| Dec 31, 2019 | 184.60M | -30.58% |
| Dec 31, 2018 | 265.90M | -41.25% |
| Dec 29, 2017 | 452.60M | 241.07% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.91B |
| Johnson & Johnson | 377.51B |
| AbbVie | 339.94B |
| Novo Nordisk | 305.41B |
| UnitedHealth Group | 275.86B |
| Novartis AG | 236.71B |
| Abbott Laboratories | 229.69B |
| AstraZeneca | 218.74B |